Coherus Oncology, Inc. Total Long-Term Debt
Coherus Oncology, Inc. (CHRS) had Total Long-Term Debt of $73.66 million as of 2019-12-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2020-05-07
- 2019-12-31: Long-term Debt $73.66M.
- 2019-06-30: Long-term Debt $73.29M.
- 2019-03-31: Long-term Debt $73.12M.
- 2018-12-31: Long-term Debt $0.00.
| Period end | Long-term Debt |
|---|---|
| 2019-12-31 | $73.66M 10-Q · filed 2020-05-07 |
| 2019-06-30 | $73.29M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $73.12M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-Q · filed 2019-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |